"Decline and uneven recovery from 7 common long-term conditions managed in the Catalan primary care after two pandemic years: an observational retrospective population-based study using primary care electronic health records".
Humans
Retrospective Studies
Pandemics
Diabetes Mellitus, Type 2
/ epidemiology
Electronic Health Records
Hypercholesterolemia
/ epidemiology
COVID-19
/ epidemiology
Pulmonary Disease, Chronic Obstructive
/ epidemiology
Asthma
/ epidemiology
Chronic Disease
Heart Failure
/ epidemiology
Primary Health Care
Hypertension
/ epidemiology
COVID-19
Chronic diseases
Electronic health records
Incidence
Primary care
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
14 01 2023
14 01 2023
Historique:
received:
12
09
2022
accepted:
01
12
2022
entrez:
14
1
2023
pubmed:
15
1
2023
medline:
18
1
2023
Statut:
epublish
Résumé
The incidence of chronic diseases during the COVID-19 pandemic has drastically been reduced worldwide due to disruptions in healthcare systems. The aim of our study is to analyse the trends in the incidence of 7 commonly managed primary care chronic diseases during the last 2 years of the COVID-19 pandemic in Catalonia. We performed an observational retrospective population-based study using data from primary care electronic health records from January 2018 to August 2022 (5.1 million people older than 14 years). We divided the study period into two: a pre-pandemic period (before 14 March 2020) and a pandemic period. We performed a segmented regression analysis of daily incidence rates per 100,000 inhabitants of 7 chronic diseases: type 2 diabetes mellitus (T2DM), asthma, chronic obstructive pulmonary disease (COPD), ischemic heart disease (IHD), heart failure (HF), hypertension and hypercholesterolemia. In addition, we compared annual incidence between pandemic years (2020, 2021 and 2022) and 2019. Associated incidence rate ratios (IRR) were also calculated. Finally, we estimated the number of expected diagnoses during the pandemic period using data from 2019 and we compared it with the observed data. We analysed 740,820 new chronic diseases' diagnoses. Daily incidence rates of all 7 chronic diseases were drastically interrupted on 14 March 2020, and a general upward trend was observed during the following months. Reductions in 2020 were around 30% for all conditions except COPD which had greater reductions (IRR: 0.58 [95% CI: 0.57 to 0.6]) and HF with lesser drops (IRR: 0.86 [95% CI: 0.84 to 0.88]). Some of the chronic conditions have returned to pre-pandemic diagnosis levels, except asthma, COPD and IHD. The return to pre-pandemic diagnosis levels compensated for the drops in 2020 for T2DM and HF, but not for hypertension which presented an incomplete recovery. We also observed an excess of hypercholesterolemia diagnoses of 8.5% (95%CI: 1.81% to 16.15%). Although primary care has recovered the pre-pandemic diagnosis levels for some chronic diseases, there are still missing diagnoses of asthma, COPD and IHD that should be addressed.
Sections du résumé
BACKGROUND
The incidence of chronic diseases during the COVID-19 pandemic has drastically been reduced worldwide due to disruptions in healthcare systems. The aim of our study is to analyse the trends in the incidence of 7 commonly managed primary care chronic diseases during the last 2 years of the COVID-19 pandemic in Catalonia.
METHODS
We performed an observational retrospective population-based study using data from primary care electronic health records from January 2018 to August 2022 (5.1 million people older than 14 years). We divided the study period into two: a pre-pandemic period (before 14 March 2020) and a pandemic period. We performed a segmented regression analysis of daily incidence rates per 100,000 inhabitants of 7 chronic diseases: type 2 diabetes mellitus (T2DM), asthma, chronic obstructive pulmonary disease (COPD), ischemic heart disease (IHD), heart failure (HF), hypertension and hypercholesterolemia. In addition, we compared annual incidence between pandemic years (2020, 2021 and 2022) and 2019. Associated incidence rate ratios (IRR) were also calculated. Finally, we estimated the number of expected diagnoses during the pandemic period using data from 2019 and we compared it with the observed data.
RESULTS
We analysed 740,820 new chronic diseases' diagnoses. Daily incidence rates of all 7 chronic diseases were drastically interrupted on 14 March 2020, and a general upward trend was observed during the following months. Reductions in 2020 were around 30% for all conditions except COPD which had greater reductions (IRR: 0.58 [95% CI: 0.57 to 0.6]) and HF with lesser drops (IRR: 0.86 [95% CI: 0.84 to 0.88]). Some of the chronic conditions have returned to pre-pandemic diagnosis levels, except asthma, COPD and IHD. The return to pre-pandemic diagnosis levels compensated for the drops in 2020 for T2DM and HF, but not for hypertension which presented an incomplete recovery. We also observed an excess of hypercholesterolemia diagnoses of 8.5% (95%CI: 1.81% to 16.15%).
CONCLUSIONS
Although primary care has recovered the pre-pandemic diagnosis levels for some chronic diseases, there are still missing diagnoses of asthma, COPD and IHD that should be addressed.
Identifiants
pubmed: 36641483
doi: 10.1186/s12875-022-01935-0
pii: 10.1186/s12875-022-01935-0
pmc: PMC9840158
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9Informations de copyright
© 2023. The Author(s).
Références
Nat Commun. 2022 Oct 8;13(1):5930
pubmed: 36209210
Int J Environ Res Public Health. 2021 May 17;18(10):
pubmed: 34067807
BMJ. 2020 Apr 6;369:m1401
pubmed: 32253175
BMJ. 2021 Feb 9;372:n339
pubmed: 33563590
PLoS One. 2014 Oct 20;9(10):e109706
pubmed: 25329578
BMJ Qual Saf. 2022 Jul;31(7):503-514
pubmed: 34642228
Int J Environ Res Public Health. 2022 Jun 02;19(11):
pubmed: 35682418
Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):29-37
pubmed: 22036238
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
J Intern Med. 2021 Apr;289(4):450-462
pubmed: 33020988
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016
Front Public Health. 2021 Oct 15;9:728768
pubmed: 34722440
Prev Chronic Dis. 2021 Jun 17;18:E62
pubmed: 34138696
Circulation. 2019 Jun 18;139(25):e1082-e1143
pubmed: 30586774
Diabetes Res Clin Pract. 2021 Dec;182:109127
pubmed: 34752800
Lancet Oncol. 2020 Aug;21(8):1035-1044
pubmed: 32702311
BMC Fam Pract. 2020 Oct 10;21(1):208
pubmed: 33038926
BMC Emerg Med. 2021 Nov 20;21(1):143
pubmed: 34800973
Fam Pract. 2022 Jul 21;:
pubmed: 35861148
Med Care. 2022 Sep 1;60(9):673-679
pubmed: 35866561
Int J Epidemiol. 2021 Jan 23;49(6):1930-1939
pubmed: 33118037
Springerplus. 2013 Dec;2(1):51
pubmed: 23450738
Health Sci Rep. 2021 Oct 01;4(4):e386
pubmed: 34622020
Med Clin (Barc). 2012 May 19;138(14):617-21
pubmed: 22444996
Aging Clin Exp Res. 2020 Jul;32(7):1189-1194
pubmed: 32458356
PLoS One. 2022 Jul 6;17(7):e0271049
pubmed: 35793324
Lancet Public Health. 2020 Oct;5(10):e543-e550
pubmed: 32979305
ESMO Open. 2021 Jun;6(3):100157
pubmed: 34015642
Clin Epidemiol. 2019 Dec 03;11:1015-1024
pubmed: 31819655
Gac Sanit. 2022;36 Suppl 1:S36-S43
pubmed: 35781146